The state Won’t Buy Pfizer, MS As Local Outputs Jumps: Report

New Delhi: India will not buy Pfizing/BioNTech and Moderna shots from COVID-19, according to three government sources, mainly as domestic output of easier and more affordable vaccines is increasing.

This means that, in the two most populous countries in the world, China and India, the globally popular vaccines their makers promised not to sell to private parties during the pandemic are currently not available.

The Indian government has also declined to meet the US companies’ requests for legal protection over any side-effects from the use of their shots, which are currently made only in the United States or Europe, two of the sources said.

No company has received such protection in India.

“Earlier, there was a shortage, there was a need,” said one of the sources, referring to India’s appeal to the companies in April for vaccines when infections exploded and shots were in short supply.

“Their price will be high. Why should we take on their conditions?”

A second source said: “The government will not buy Pfizer and Moderna vaccines. They are free to have private tie-ups after necessary regulatory clearances. But sovereign indemnity is clearly something we can’t give”.

A Pfizer spokesperson in India said discussions were ongoing and it remained committed to bring the vaccine to the country.

The company reiterated that “during the pandemic phase, it would supply the COVID-19 vaccine only to central governments and supra-national organisations”.

Moderna and India’s health ministry did not immediately respond to requests for comment.

Moderna, through its Indian partner Cipla, already has emergency-use authorisation in India for its vaccine, which, like the Pfizer one, needs ultra-cold storage – facilities that much of India lacks.

Both vaccines cost several times more than India’s main shot, Covishield, a licensed version of the AstraZeneca drug.

India’s monthly domestic output has trebled since April and will reach 300 million doses in October, according to Health Minister Mansukh Mandaviya, who on Monday announced a restart of India’s vaccine exports from the October quarter.

The government, however, is expected to buy locally filled and finished doses of Johnson & Johnson’s vaccine, Reuters reported on Monday.

Medically Speaking

Recent Posts

Harness the Power of Rice Water

Rice water, rich in inositol, antioxidants, vitamins, and minerals, protects hair from sunlight damage and…

12 hours ago

“8 Powerful Herbs and Supplements to Beat Bloating and Boost Your Gut Health Naturally”

Natural Remedies for Bloating: 8 Herbs and Supplements That Work Wonders for Your Gut Health…

12 hours ago

“Unlock the Power of Oil Pulling: Discover How This Simple Practice Improves Oral Health and Freshens Your Breath”

Benefits of Oil Pulling: Stops Bad Breath, Keeps Gums Healthy, But Can't Replace Brushing Oil…

13 hours ago

WHY DO YOU EXPERIENCE RUNNY NOSE AFTER EATING SPICY FOOD?

Spicy food – whether it’s a dash of chili in your curry, a spoonful of…

13 hours ago

“4 Simple Tests to Spot Adulterated Wheat Flour: Protect Your Health with These Easy Checks”

How To Identify Adulterated Wheat Flour? Try These 4 Easy Tests Wheat flour is a…

13 hours ago

“Unlock the Power of Jaggery: 10 Surprising Health Benefits of Eating It After Every Meal”

Reasons That Will Make You Eat Jaggery After Every Meal (Potential Health Benefits Inside) Jaggery,…

13 hours ago